JFIL — what changed in the latest 10-Q
A section-by-section comparison of JFIL's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-07-13 vs the prior 10-Q · 2026-01-13
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +10 | −10 | ~7 | 5 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 0 |
| Legal proceedings | Text added/removed | 0 | 0 | ~1 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Risk factors, Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-07-13
From the third quarter of the year ended February 29, 2020, the Company began its new business line of providing technical support services for development of new nutrition food products to sell to customers in USA. However, this new business line remained pre-revenue throughout the quarter ended at…
No other expenses incurred during the three-month periods ended May 31, 2026 and 2025.
For the three months ending May 31, 2026, we recognized a net loss of $29,731 compared to the net loss of $19,190 for the corresponding period in 2025.
As of May 31, 2026, the Company had current assets of $9,725, primarily comprising of cash of $1,715 and prepaid expenses of $8,010, and current liabilities of $1,459,548, resulting in a working capital deficit of $1,449,823. The Company had limited profitable operation activities and has an accumul…
Our net cash used in operating activities increased by $15,178 in the three months ended May 31, 2026 compared to the net cash used in operating activities in the three months ending May 31, 2025. The increase in net cash used in operating activities was primarily due to higher net loss of $10,541 i…
Text removed vs the prior filing · source: 10-Q · 2026-01-13
From the third quarter of the year ended February 29, 2020, the Company began providing technical support services for development of new nutrition food products to sell to customers in USA. No significant revenue has been generated from this new business line.
For the nine months ended November 30, 2025 compared to the nine months ended November 30, 2024
The major components of our operating expenses for the nine months ended November 30, 2025 and 2024 are outlined in the table below:
The $628 increase in our operating costs for the nine months ended November 30, 2025 compared to nine months ended November 30, 2024, was mainly due to an increase in OTC service expense of $450 and an increase of $207 in professional fee.
No other expenses incurred during the three and nine-month periods ended November 30, 2025 and 2024.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice